Drug Name: 

REGN2477

Drug Description: 
Activin A Antibody
Target Condition: 
Fibrodysplasia Ossificans Progressiva (FOP)
Rank: 
50
Phase: 
Phase 1

NOW APPROVED IN THE UNITED STATES